Redeye updates its estimates and fair value range following CoinShares' Q1 2025 report. Asset management fee came in 7% light of expectations while CSCM beat estimates by 8%. Paired with lower bonus accrual, EBITDA came in 14% higher than anticipated. The apparent steep fall in AUM likely overshadowed the profitability beat, resulting in a ~4% share sell-off. However, AUM is measured at the end of the period, and Cryptocurrencies have recovered since the Q1 low. CoinShares is valued at EV/EBITDA of 5.2x this year, offers crypto upside while limited downside due to its balance sheet, and a ~4% dividend yield. Thus, an attractive yield while investors wait for a re-rating driven by CoinShares US listing plans.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/